Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05477277

Adverse Outcomes and Mortality in Liver Transplant

Conditions: End Stage Liver DIsease, Sarcopenia, Sarcopenic Obesity, Cirrhosis

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 100

Sponsor: Mayo Clinic

Location: Mayo Clinic Arizona Phoenix Arizona

Summary

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Eligibility Criteria

Inclusion Criteria: 1. All patients with end-stage liver disease undergoing evaluation for liver transplantation 2. Patient clinically indicated for MRI during transplant candidacy evaluation 3. Adult Exclusion Criteria: 1\. Contra indication to MRI

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05477277). StuddyBuddy aggregates publicly available trial information.